<DOC>
	<DOCNO>NCT00150787</DOCNO>
	<brief_summary>A double-blind follow-up trial assess long term safety Levetiracetam per adverse event reporting , physical neurological examination vital sign</brief_summary>
	<brief_title>Monotherapy With Levetiracetam Carbamazepine Patients Suffering From Epilepsy .</brief_title>
	<detailed_description />
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Epilepsy , Tonic-Clonic</mesh_term>
	<mesh_term>Epilepsy , Generalized</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<mesh_term>Carbamazepine</mesh_term>
	<mesh_term>Piracetam</mesh_term>
	<criteria>Subjects confirm diagnosis epilepsy . Subjects experience past unprovoked partial seizure ( IA , IB , IC clear focal origin ) , generalize tonicclonic seizure ( without clear focal origin ) , classifiable accord International Classification Epileptic Seizures Subjects come N01061 monotherapy trial doubleblind continuation investigational product beneficial . Need additional AED .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Monotherapy , epilepsy</keyword>
	<keyword>Levetiracetam</keyword>
	<keyword>Keppra</keyword>
</DOC>